Skip to main content
Premium Trial:

Request an Annual Quote

Funding Update: NSF Bioinformatics Grants Awarded Oct 23 — Nov 19, 2013


Modeling Protein Degradation — Evaluation of Strategies and Targets
Start Date: Nov. 15, 2013
Expires: Oct. 31, 2015
Awarded Amount to Date: $300,000
Principal Investigators: Christine Vogel, Dennis Shasha
Sponsor: New York University

According to the abstract, the funds will support the use of mass spectrometry and bioinformatics to combine proteomic data such as protein ubiquitination status and degradation, with information on protein sequence and structure to discover features that impact protein stability.

Development and Application of Multi-scale Modeling for Biomolecular Association
Start Date: May 1, 2014
Expires: April 30, 2019
Awarded Amount to Date: $351,038
Principal Investigators: Chia-en Chang
Sponsor: University of California, Riverside

According to the abstract, the investigators will combine "multi-level coarse-grained and atomistic simulations to efficiently and accurately model molecular associations and kinetic enhancement of the enzymes and nanoparticle systems." The methods developed as part of this project are expected to "improve understanding of protein-ligand binding kinetics and assist the design of nanostructures, nanoparticles, and engineered enzymes."

Filed under

The Scan

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.

Mitochondrial Replacement Therapy Embryos Appear Largely Normal in Single-Cell 'Omics Analyses

Embryos produced with spindle transfer-based mitochondrial replacement had delayed demethylation, but typical aneuploidy and transcriptome features in a PLOS Biology study.

Cancer Patients Report Quality of Life Benefits for Immune Checkpoint Inhibitors

Immune checkpoint inhibitor immunotherapy was linked in JAMA Network Open to enhanced quality of life compared to other treatment types in cancer patients.

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.